Ï㽶ÊÓƵ

Skip to main content
Sankar Swaminathan
No Rating Available
(Learn About Our Rating System)

Sankar Swaminathan, MD

Languages spoken: English

Clinical Locations

Ï㽶ÊÓƵ of Utah Hospital

Infectious Diseases, Area E
Salt Lake City
801-585-2031
  • Sankar Swaminathan, MD has specialized expertise in the treatment of infectious diseases. He is board certified in Internal Medicine and Infectious Diseases. His main clinical focus is in the diagnosis and treatment of infections in immunocompromised patients, including cancer patients and transplant recipients. He has integrated a research program funded by the National Cancer institute on the role of viruses in cancers into his clinical practice.

    Board Certification

    American Board of Internal Medicine
    American Board of Internal Medicine (Sub: Infectious Disease)
    American Board of Internal Medicine (Sub: Infectious Disease)
  • Sankar Swaminathan, MD has specialized expertise in the treatment of infectious diseases. He is board certified in Internal Medicine and Infectious Diseases. His main clinical focus is in the diagnosis and treatment of infections in immunocompromised patients, including cancer patients and transplant recipients. He has integrated a research program funded by the National Cancer institute on the role of viruses in cancers into his clinical practice.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Pathology -Adjunct
    Academic Divisions Infectious Diseases
    Board Certification
    American Board of Internal Medicine
    American Board of Internal Medicine (Sub: Infectious Disease)
    American Board of Internal Medicine (Sub: Infectious Disease)

    Education history

    Research Fellow Infectious Disease - Beth Israel Hospital, Brigham & Women's Hospital, Dana Farber Cancer Institute Research Fellow
    Research Fellow Microbiology and Molecular Genetics - Harvard Medical School Research Fellow
    Fellowship Infectious Disease - Beth Israel Hospital, Brigham & Women's Hospital, Dana Farber Cancer Institute Clinical Fellow
    Fellowship Medicine - Harvard Medical School Clinical Fellow
    Residency Internal Medicine - Ï㽶ÊÓƵ of Chicago Medical Center Resident
    Internship Internal Medicine - Ï㽶ÊÓƵ of Chicago Medical Center Intern
    Graduate Training Microbiology and Immunology - Emory Ï㽶ÊÓƵ School of Medicine M.S.
    Professional Medical Medicine - Emory Ï㽶ÊÓƵ School of Medicine M.D.
    Undergraduate Biochemistry and Molecular Biology, magna cum laude - Harvard College A.B.

    Selected Publications

    Journal Article

    1. Harmon KG, Pottinger PS, Baggish AL, Drezner JA, Luks AM, Thompson AA, Swaminathan S (2020). Comorbid Medical Conditions in Young Athletes: Considerations for Preparticipation Guidance During the COVID-19 Pandemic. Sports Health, 12(5), 456-458. ()
    2. Verma D, Church TM, Swaminathan S (2020). Epstein-Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters. Proc Natl Acad Sci U S A, 117(23), 13044-13055. ()
    3. Li D, Mosbruger T, Verma D, Swaminathan S (2020). Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription. J Virol, 94(2). ()
    4. Agrawal R, Durupt G, Verma D, Montgomery M, Vieira-de Abreu A, Taylor C, Swaminathan S, Fisher SJ (2019). MicroRNA-7a overexpression in VMH restores the sympathoadrenal response to hypoglycemia. JCI Insight, 4(20). ()
    5. Li D, Swaminathan S (2019). Human IFIT proteins inhibit lytic replication of KSHV: A new feed-forward loop in the innate immune system. PLoS Pathog, 15(2), e1007609. ()
    6. Sundermann AJ, Clancy CJ, Pasculle AW, Liu G, Cumbie RB, Driscoll E, Ayres A, Donahue L, Pergam SA, Abbo L, Andes DR, Chandrasekar P, Galdys AL, Hanson KE, Marr KA, Mayer J, Mehta S, Morris MI, Perfect J, Revankar SG, Smith B, Swaminathan S, Thompson GR, Varghese M, Vazquez J, Whimbey E, Wingard JR, Nguyen MH (2018). How Clean Is the Linen at My Hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer Centers. Clin Infect Dis, 68(5), 850-853. ()
    7. Fu W, Verma D, Burton A, Swaminathan S (2019). Cellular RNA Helicase DHX9 Interacts with the Essential Epstein-Barr Virus (EBV) Protein SM and Restricts EBV Lytic Replication. J Virol, 93(4). ()
    8. Li D, Fu W, Swaminathan S (2018). Continuous DNA replication is required for late gene transcription and maintenance of replication compartments in gammaherpesviruses. PLoS Pathog, 14(5), e1007070. ()
    9. Church TM, Verma D, Thompson J, Swaminathan S (2018). Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV. J Virol, 92(6). ()
    10. Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, Cooper B, Dubberke ER, Engemann AM, Freifeld AG, Greene JN, Ito JI, Kaul DR, Lustberg ME, Montoya JG, Rolston K, Satyanarayana G, Segal B, Seo SK, Shoham S, Taplitz R, Topal J, Wilson JW, Hoffmann KG, Smith C (2016). Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 14(7), 882-913. ()
    11. Verma D, Thompson J, Swaminathan S (2016). Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function. Proc Natl Acad Sci U S A, 113(13), 3609-14. ()
    12. Baglio SR, van Eijndhoven MA, Koppers-Lalic D, Berenguer J, Lougheed SM, Gibbs S, Lveill N, Rinkel RN, Hopmans ES, Swaminathan S, Verkuijlen SA, Scheffer GL, van Kuppeveld FJ, de Gruijl TD, Bultink IE, Jordanova ES, Hackenberg M, Piersma SR, Knol JC, Voskuyl AE, Wurdinger T, Jimnez CR, Middeldorp JM, Pegtel DM (2016). Sensing of latent EBV infection through exosomal transfer of 5'pppRNA. Proc Natl Acad Sci U S A, 113(5), E587-96. ()
    13. Thompson J, Verma D, Li D, Mosbruger T, Swaminathan S (2016). Identification and Characterization of the Physiological Gene Targets of the Essential Lytic Replicative Epstein-Barr Virus SM Protein. J Virol, 90(3), 1206-21. ()
    14. Verma D, Li DJ, Krueger B, Renne R, Swaminathan S (2015). Identification of the physiological gene targets of the essential lytic replicative Kaposi's sarcoma-associated herpesvirus ORF57 protein. J Virol, 89(3), 1688-702. ()
    15. Li DJ, Verma D, Mosbruger T, Swaminathan S (2014). CTCF and Rad21 act as host cell restriction factors for Kaposi's sarcoma-associated herpesvirus (KSHV) lytic replication by modulating viral gene transcription. PLoS Pathog, 10(1), e1003880. ()

    Case Report

    1. Swaminathan P, Swaminathan S (2020). Nail Findings in Chikungunya Infection. Open Forum Infect Dis, 7(2), ofaa031. ()

    Letter

    1. Swaminathan S, Schlaberg R, Lewis J, Hanson KE, Couturier MR (2016). Fatal Zika Virus Infection with Secondary Nonsexual Transmission. [Letter to the editor]. N Engl J Med, 375(19), 1907-1909. ()